医学
肝移植
工作组
移植
活体肝移植
梅德林
协商一致会议
循证医学
重症监护医学
普通外科
外科
内科学
替代医学
病理
计算机科学
政治学
法学
操作系统
作者
Abdul Hakeem,Johns Shaji Mathew,Carmen Vinaixa Aunés,Alessandra Mazzola,Felipe Alconchel,In‐Young Yoon,Giuliano Testa,Nazia Selzner,Shiv Kumar Sarin,Kwang‐Woong Lee,Arvinder S. Soin,James J. Pomposelli,Krishna Menon,Neerav Goyal,Venugopal Kota,Samir Abu‐Gazala,Manuel I. Rodríguez-Dávalos,Rajesh Rajalingam,Dharmesh Kapoor,François Durand
出处
期刊:Transplantation
[Wolters Kluwer]
日期:2023-08-28
卷期号:107 (10): 2203-2215
被引量:24
标识
DOI:10.1097/tp.0000000000004769
摘要
Small-for-size syndrome (SFSS) is a well-recognized complication following liver transplantation (LT), with up to 20% developing this following living donor LT (LDLT). Preventing SFSS involves consideration of factors before the surgical procedure, including donor and recipient selection, and factors during the surgical procedure, including adequate outflow reconstruction, graft portal inflow modulation, and management of portosystemic shunts. International Liver Transplantation Society, International Living Donor Liver Transplantation Group, and Liver Transplant Society of India Consensus Conference was convened in January 2023 to develop recommendations for the prediction and management of SFSS in LDLT. The format of the conference was based on the Grading of Recommendations, Assessment, Development, and Evaluation system. International experts in this field were allocated to 4 working groups (diagnosis, prevention, anesthesia, and critical care considerations, and management of established SFSS). The working groups prepared evidence-based recommendations to answer-specific questions considering the currently available literature. The working group members, independent panel, and conference attendees served as jury to edit and confirm the final recommendations presented at the end of the conference by each working group separately. This report presents the final statements and evidence-based recommendations provided by working group 2 that can be implemented to prevent SFSS in LDLT patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI